A Phase 1 Study of CPI-1205, a Small Molecule Inhibitor of EZH2, in Patients with B-Cell Lymphomas

Type of Cancer
Lymphoma

Site
Hackensack

Sponsor
Constellation

Protocol Number
Constellation 1205-01

To Learn More Call
201-510-0910